Drug
Cevimeline
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Squamous Cell Carcinoma | 6 | 16.3 | 16.4 | signal |
| 2 | Pulmonary Arterial Hypertension | 6 | 10.5 | 10.6 | signal |
| 3 | Hereditary Angioedema | 4 | 9.8 | 9.8 | signal |
| 4 | Transfusion | 4 | 9.7 | 9.8 | signal |
| 5 | Systemic Lupus Erythematosus | 13 | 9.4 | 9.5 | signal |
| 6 | Deformity | 3 | 8.2 | 8.2 | signal |
| 7 | Coeliac Disease | 3 | 7.8 | 7.9 | signal |
| 8 | Eye Irritation | 17 | 7.8 | 8.0 | signal |
| 9 | Musculoskeletal Disorder | 5 | 6.7 | 6.7 | signal |
| 10 | Product Dose Omission In Error | 7 | 6.7 | 6.7 | signal |
| 11 | Psoriatic Arthropathy | 10 | 6.4 | 6.4 | signal |
| 12 | Device Defective | 3 | 4.7 | 4.8 | signal |
| 13 | Needle Issue | 5 | 4.5 | 4.5 | signal |
| 14 | Tardive Dyskinesia | 4 | 3.6 | 3.6 | signal |
| 15 | Incorrect Dose Administered By Device | 3 | 3.0 | 3.0 | no signal |
| 16 | Dermatitis Atopic | 5 | 2.6 | 2.6 | no signal |